MARKETSStocks End Down After Wall Street Worries Rate Cut Won't Be EnoughBy Joseph WoelfelMar 3, 2020 4:14 PM EST
PRESS RELEASESROSEN, A HIGHLY RANKED FIRM, Continues To Investigate Securities Claims Against QIAGEN N.V.By Business WireMar 26, 2020 3:30 PM EDT
PRESS RELEASESQIAGEN Names Thierry Bernard As Chief Executive OfficerBy Business WireMar 24, 2020 1:00 PM EDT
PRESS RELEASESQIAGEN Releases QIAstat-Dx Test Kit To The U.S. As First Syndromic Test For Detection Of SARS-CoV-2 Coronavirus Under New FDA PolicyBy Business WireMar 24, 2020 5:30 AM EDT
PRESS RELEASESQIAGEN Launches QIAstat-Dx Test Kit For Detection Of SARS-CoV-2 Coronavirus In Europe Following CE MarkingBy Business WireMar 18, 2020 7:00 PM EDT
PRESS RELEASESQIAGEN Dramatically Ramping Up Global Production Capacity For RNA Extraction Kits For Use In Detection Of SARS-CoV-2 CoronavirusBy Business WireMar 17, 2020 4:09 PM EDT
PRESS RELEASESINVESTIGATION REMINDER: The Schall Law Firm Announces It Is Investigating Claims Against Qiagen N.V. And Encourages Investors With Losses In Excess Of $100,000 To Contact The FirmBy Business WireMar 16, 2020 12:19 PM EDT
PRESS RELEASESQIAGEN Gains BARDA Funding For Approval Process Of QIAstat-Dx Test Kit For SARS-CoV-2 CoronavirusBy Business WireMar 13, 2020 9:01 AM EDT
PRESS RELEASESSHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of QIAGEN N.V. - QGENBy PR NewswireMar 9, 2020 1:34 PM EDT
PRESS RELEASESMoore Kuehn Encourages Investors Of TIVO, MEET, QGEN, And GCAP To Contact Law FirmBy PR NewswireMar 5, 2020 2:15 PM EST
MARKETSStocks End Down After Wall Street Worries Rate Cut Won't Be EnoughBy Joseph WoelfelMar 3, 2020 4:14 PM EST
PRESS RELEASESQIAGEN Announces 20-F Annual Report Filing For 2019 ResultsBy Business WireMar 2, 2020 8:19 AM EST
PRESS RELEASESQIAGEN Announces Worldwide Shipments Of QIAstat-Dx Test Kits For SARS-CoV-2By Business WireFeb 26, 2020 4:00 PM EST
PRESS RELEASESQIAGEN's QuantiFERON®-TB Gold Plus To Be Adopted For Latent TB Testing In NigeriaBy Business WireFeb 19, 2020 4:05 PM EST
PRESS RELEASESQIAGEN Reports Results For Fourth Quarter And Full-Year 2019By Business WireFeb 4, 2020 4:05 PM EST
PRESS RELEASESQIAGEN Launches FFPE And Liquid Biopsy PIK3CA Diagnostics In Europe To Enhance Precision Medicine In Advanced Breast CancerBy Business WireFeb 3, 2020 4:06 PM EST
PRESS RELEASESQIAGEN Builds On Global Collaboration With Amgen For Companion Diagnostic Development In Non-small Cell Lung CancerBy Business WireJan 13, 2020 4:05 PM EST
PRESS RELEASESQIAGEN N.V. To Report Fourth Quarter And Full Year 2019 ResultsBy Business WireJan 10, 2020 5:17 AM EST
PRESS RELEASESQIAGEN Celebrates Surpassing 2,500 Cumulative Placements Of QIAsymphonyBy Business WireJan 9, 2020 4:05 PM EST
MARKETSStocks Close at Records; Nasdaq Higher for 11th Consecutive SessionBy Joseph WoelfelDec 26, 2019 4:26 PM EST
MARKETSQiagen Jumps on Report Thermo Fisher Is Considering a BidBy Joseph WoelfelNov 14, 2019 9:35 AM EST
